ArticleInternational journal of clinical oncology2024

Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.

Sho Iwaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.